You are here: Industry Insights > Altasciences

News List

Altasciences Names Wendell Davis VP, Pathology contractpharma
February 08, 2022
Davis brings experience evaluating small molecules, biologics, oligonucleotide, and an array of RNA therapeutics modalities.
Altasciences and Virpax Pharmaceuticals Enter Clinical Trial Partnership contractpharma
January 21, 2022
Altasciences to conduct first-in-human study of Epoladerm for chronic pain associated with osteoarthritis of the knee.
Altasciences Acquires Sinclair Research contractpharma
January 05, 2022
Continues to expand preclinical platform.
Altasciences Acquires Calvert Laboratories contractpharma
May 08, 2021
Altasciences, a CRO/CDMO supporting all crucial steps in early-stage drug development, from lead candidate selection to clinical proof of concept, has completed the acquisition of Calvert Laboratories, a preclinical CRO located on the U.S. East Coast.
Altasciences Doubles Size of PA CDMO Facility contractpharma
March 11, 2021
The additional 35,000-sq.-ft. building in Philadelphia will include warehouse and cGMP manufacturing suites.
Altasciences Contributes to Vibegron Approval contractpharma
February 25, 2021
Altasciences has contributed to the recent FDA approval of Vibegron, a beta-3 adrenergic receptor (β3) agonist for the treatment of overactive bladder, conducting multiple early phase clinical trialsfor Urovant Sciences.
Altasciences Names Chief Medical Officer contractpharma
June 10, 2020
Altasciences has appointed Dr. Gaetano Morelli as chief medical officer, effective May 14, 2020.
Altasciences Completes Phase I Study on Gimsilumab for ARDS in COVID-19 americanpharmaceuticalreview
April 01, 2020
Altasciences has completed a Phase I study for the development of gimsilumab, a fully human monoclonal antibody that targets granulocyte-macrophage colony stimulating factor (GM-CSF).
Altasciences Completes Phase I Study in COVID-19 Patients contractpharma
March 30, 2020
Gimsilumab, a monoclonal antibody, is being evaluated in patients with or at risk of developing acute respiratory distress syndrome.
Altasciences, Amador Bioscience Enter Strategic Collaboration contractpharma
March 19, 2020
The partnership aims to expand world-class capabilities and resources to promote drug development in China and North America.

Previous page 1 2 Next page